Treatment strategies for patients with relapsed or refractory Hodgkin’s disease
- 1 July 1995
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 6 (6) , 517-518
- https://doi.org/10.1093/oxfordjournals.annonc.a059236
Abstract
James O. Armitage, M.D; Treatment strategies for patients with relapsed or refractory Hodgkin's disease, Annals of Oncology, Volume 6, Issue 6, 1 July 1995, PaThis publication has 7 references indexed in Scilit:
- Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy [see comments]Blood, 1994
- Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.Journal of Clinical Oncology, 1992
- Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease.Journal of Clinical Oncology, 1991
- Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988Blood, 1991
- Salvage chemotherapy in Hodgkin's diseaseAnnals of Oncology, 1990
- High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaNew England Journal of Medicine, 1987
- Prolonged Disease-Free Survival in Hodgkin's Disease with MOPP Reinduction After First RelapseAnnals of Internal Medicine, 1979